statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Accelerate Diagnostics, Inc. (NASDAQ:AXDX - Get Free Report) CEO Jack Phillips sold 15,887 shares of the company's stock in a transaction on Thursday, April 4th. The stock was sold at an average...

Insider Selling: Accelerate Diagnostics, Inc. (NASDAQ:AXDX) CEO Sells $13,980.56 in Stock

Analysts at StockNews.com assumed coverage on shares of Accelerate Diagnostics (NASDAQ:AXDX - Get Free Report) in a research note issued to investors on Thursday. The brokerage set a "hold" rating on...

Accelerate Diagnostics (NASDAQ:AXDX) Coverage Initiated at StockNews.com

William Blair restated their outperform rating on shares of Accelerate Diagnostics (NASDAQ:AXDX - Free Report) in a research note published on Tuesday, RTT News reports. William Blair also issued...

William Blair Reaffirms Outperform Rating for Accelerate Diagnostics (NASDAQ:AXDX)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Staar Surgical (STAA Research Report), DarioHealth (DRIO Rese...

Analysts Have Conflicting Sentiments on These Healthcare Companies: Staar Surgical (STAA), DarioHealth (DRIO) and Accelerate Diagnostics (AXDX)

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Accelerate Diagnostics price target lowered by $1 at Craig-Hallum, here's why

Accelerate Diagnostics (AXDX) has disclosed a new risk, in the Share Price & Shareholder Rights category. Accelerate Diagnostics has positioned its...

Stockholders Beware: Accelerate Diagnostics' Surge in Authorized Shares Signals Potential Dilution Risk

Analysts at StockNews.com started coverage on shares of Accelerate Diagnostics (NASDAQ:AXDX  Get Free Report) in a research note issued to investors on Wednesday. The firm set a...

StockNews.com Initiates Coverage on Accelerate Diagnostics (NASDAQ:AXDX)

InvestorPlace - Stock Market News, Stock Advice & Trading Tips
AXDX stock results show that Accelerate Diagnostics missed analyst estimates for earnings per share and missed on revenue for the fourth...

AXDX Stock Earnings: Accelerate Diagnostics Misses EPS, Misses Revenue for Q4 2023

Accelerate Diagnostics Inc. (AXDX) Q4 2023 Earnings Call Transcript...

Accelerate Diagnostics Inc. (AXDX) Q4 2023 Earnings Call Transcript

Accelerate Diagnostics, Inc. is an in vitro diagnostics company, which engages in the provision of solutions that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections. It also focuses on developing and commercializing innovative instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens. The firm's products include Accelerate Pheno and Accelerate PhenoTest. The company was founded in 1982 and is headquartered in Tucson, AZ.

Volume	137,854.00
52-Wk High	$11.90
52-Wk Low	$0.73

AXDX Accelerate Diagnostics Inc

About

Feed

News

Sentiment

Earnings

Fundamentals